AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Kevin Martin

Examiner Kevin Martin appears to be about average relative to their peer examiners. Their lifetime grant ratio is 40.5%, they average 1.80 office actions per granted patent, and their rejection profile leans toward §112 and elevated §112 usage.

Difficulty vs AU Very Hard
Difficulty vs Group Very Hard
Difficulty vs TC Very Easy
Difficulty vs USPTO About Average
Average OA / Grant 1.80
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
4 years (2023-2026)
Phone
(571) 270-0917
Predicted Supervisor
Jeffrey Murray
Supervisor Phone
(571) 272-9023
Tech Center
1600 - Biotechnology and Organic
Group
1620 - Biomedicinal Chemistry

Metrics

Applications Evaluated
163
Granted Applications
66
Non-Granted Applications
97
Avg OA / Grant
1.80
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1624
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 40.5% 1.80
Art Unit 32 55.8% 1.59
Group 248 48.3% 1.76
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2023; examiner may not yet have been active in the available dataset.
2023 8 4 50.0%
2024 51 35 68.6%
2025 81 27 33.3%
2026 23 0 0.0%

66 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 155 0.6% 16.1% 34.2% 30.3%
2 86 0.0% 8.1% 30.2% 48.8%
3 24 0.0% 4.2% 33.3% 50.0%
4 7 0.0% 0.0% 42.9% 57.1%
5 1 0.0% 0.0% 0.0% 100.0%
6 1 0.0% 0.0% 0.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
4.3%
2023
0.0%
2024
0.0%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.